-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Insulet, Lowers Price Target to $190

Benzinga·10/12/2026 18:29:02
Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $275 to $190.